Sagar Acharya
Overview
Explore the profile of Sagar Acharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaudhuri S, Acharya S, Chaudhuri S
Immunotherapy
. 2022 Aug;
14(15):1263-1277.
PMID: 36004447
The disease relevance of novel therapeutic agent T11TS, established first by the authors' group, was shown to ameliorate experimental glioma through multimodal mechanistic activities. T11TS reverses immunosuppression in glioma, causing...
2.
Dalal S, Adhikary J, Roy A, Biswas S, Mukhopadhyay P, Acharya S, et al.
Mol Biol Rep
. 2022 Jun;
49(9):8369-8380.
PMID: 35713797
Background: On the background of the epidemiological link between diabetes and oral cancer, the present study aimed to analyze the potential involvement of selected glucose transporters (GLUT1/GLUT3/GLUT4), if any, in...
3.
Acharya S, Chatterjee S, Chaudhuri S, Singh M, Bhattacharya D, Bhattacharjee M, et al.
Cancer Invest
. 2021 Sep;
39(10):854-870.
PMID: 34569407
The novel anti-neoplastic glycopeptide T11TS retards glioma both in clinical samples and models. This study investigates the correlation between altering the glioma microenvironment with glioma arrest and death. Flow cytometry,...
4.
Chaudhuri S, Singh M, Bhattacharya D, Acharya S, Chatterjee S, Kumar P, et al.
J Neurooncol
. 2014 Jul;
120(1):19-31.
PMID: 25026997
T-cell-mediated immune responses are typically low in conditions of malignant glioma which has been known to cause marked immunesuppression and dysregulate major T-cell signaling molecules. Thus, T-cell-based immunotherapies are currently...
5.
Singh M, Bhattacharya D, Chaudhuri S, Acharya S, Kumar P, Santra P, et al.
Tumour Biol
. 2013 Nov;
35(3):2231-46.
PMID: 24242015
During glioma development, angiogenesis plays a crucial role in growth and vascularization of primary brain tumors. T11 target structure (T11TS), a bioactive molecule, has been documented as an anti-neoplastic agent...
6.
Kumar P, Chatterjee S, Acharya S, Kumari A, Chaudhuri S, Singh M, et al.
Cell Immunol
. 2013 Sep;
284(1-2):172-81.
PMID: 23994239
T11 target structure (T11TS), a membrane glycoprotein has been documented with anti neoplastic activity in glioma bearing animal model in our lab. In this study, we have evaluated the phagocytic...
7.
Bhattacharya D, Singh M, Chaudhuri S, Acharya S, Basu A, Chaudhuri S
J Neurooncol
. 2013 Mar;
113(1):13-25.
PMID: 23471571
The crucial role of angiogenesis in malignant glioma progression makes it a potential target of therapeutic intervention in glioma. Previous studies from our lab showed that sheep erythrocyte membrane glycopeptide...
8.
Chaudhuri S, Acharya S, Chatterjee S, Kumar P, Singh M, Bhattacharya D, et al.
Asian Pac J Cancer Prev
. 2012 Sep;
13(6):2943-8.
PMID: 22938487
Arsenic exposure is a serious health hazard worldwide. We have previously established that it may result in immune suppression by upregulating Th2 cytokines while downregulating Th1 cytokines and causing lymphocytic...
9.
Kumar P, Acharya S, Chatterjee S, Kumari A, Chaudhuri S, Singh M, et al.
Cell Immunol
. 2012 Jun;
276(1-2):176-86.
PMID: 22704241
T11 target structure (T11TS), a membrane glycoprotein has been documented with antineoplastic activity in animal model in our lab. Previously, in animal study we have documented T11TS induced cytotoxic abrogation...
10.
Chatterjee S, Acharya S, Kumar P, Chatterjee A, Chaudhuri S, Ghosh A, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2012 Jan;
44(3):259-68.
PMID: 22257732
Sheep red blood cell (SRBC), a non-specific biological response modifier that has long been used as a classical antigen, has been shown to exert an immunomodulatory and anti-tumor activities in...